Possible Patent Typo Debated As Juno, Kite IP Trial Kicks Off
Lawyers for Juno Therapeutics and Kite Pharma delivered opening statements Tuesday in Juno's infringement suit over its groundbreaking cancer immunotherapy — a potentially multibillion-dollar fight that may turn on whether a...To view the full article, register now.
Already a subscriber? Click here to view full article